Skip to content

Rapid Micro Biosystems RPID Capitalized Computer Software, Net

Capitalized Computer Software, Net at other companies

Simulations Plus logo
Simulations PlusSLP
$11.16M+1,295%

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:CapitalizedComputerSoftwareNet.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's capitalized computer software, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's capitalized computer software, net?
Rapid Micro Biosystems (RPID) reported capitalized computer software, net of $1.6M in Q1 2026.
How has Rapid Micro Biosystems's capitalized computer software, net changed year-over-year?
Rapid Micro Biosystems's capitalized computer software, net decreased by 0.0% year-over-year, from $1.6M to $1.6M.
What is the long-term trend for Rapid Micro Biosystems's capitalized computer software, net?
Over 2 years (2023 to 2025), Rapid Micro Biosystems's capitalized computer software, net has grown at a 6.9% compound annual growth rate (CAGR), from $1.4M to $1.6M.